PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PRCT vs. PSEC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


PRCTPSEC
YTD Return120.11%-20.33%
1Y Return176.28%-16.20%
3Y Return (Ann)30.75%-12.52%
Sharpe Ratio2.97-0.47
Sortino Ratio4.53-0.45
Omega Ratio1.510.93
Calmar Ratio5.35-0.36
Martin Ratio25.32-1.48
Ulcer Index7.40%8.40%
Daily Std Dev63.12%26.43%
Max Drawdown-63.51%-61.51%
Current Drawdown-6.88%-33.97%

Fundamentals


PRCTPSEC
Market Cap$5.17B$1.86B
EPS-$1.95$0.34
Total Revenue (TTM)$199.84M$566.93M
Gross Profit (TTM)$112.10M$394.29M
EBITDA (TTM)-$98.77M$311.02M

Correlation

-0.50.00.51.00.3

The correlation between PRCT and PSEC is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

PRCT vs. PSEC - Performance Comparison

In the year-to-date period, PRCT achieves a 120.11% return, which is significantly higher than PSEC's -20.33% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctoberNovember
33.33%
-19.16%
PRCT
PSEC

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PRCT vs. PSEC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and Prospect Capital Corporation (PSEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PRCT
Sharpe ratio
The chart of Sharpe ratio for PRCT, currently valued at 2.97, compared to the broader market-4.00-2.000.002.004.002.97
Sortino ratio
The chart of Sortino ratio for PRCT, currently valued at 4.53, compared to the broader market-4.00-2.000.002.004.006.004.53
Omega ratio
The chart of Omega ratio for PRCT, currently valued at 1.51, compared to the broader market0.501.001.502.001.51
Calmar ratio
The chart of Calmar ratio for PRCT, currently valued at 5.35, compared to the broader market0.002.004.006.005.35
Martin ratio
The chart of Martin ratio for PRCT, currently valued at 25.32, compared to the broader market0.0010.0020.0030.0025.32
PSEC
Sharpe ratio
The chart of Sharpe ratio for PSEC, currently valued at -0.47, compared to the broader market-4.00-2.000.002.004.00-0.47
Sortino ratio
The chart of Sortino ratio for PSEC, currently valued at -0.45, compared to the broader market-4.00-2.000.002.004.006.00-0.45
Omega ratio
The chart of Omega ratio for PSEC, currently valued at 0.93, compared to the broader market0.501.001.502.000.93
Calmar ratio
The chart of Calmar ratio for PSEC, currently valued at -0.36, compared to the broader market0.002.004.006.00-0.36
Martin ratio
The chart of Martin ratio for PSEC, currently valued at -1.48, compared to the broader market0.0010.0020.0030.00-1.48

PRCT vs. PSEC - Sharpe Ratio Comparison

The current PRCT Sharpe Ratio is 2.97, which is higher than the PSEC Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of PRCT and PSEC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
2.97
-0.47
PRCT
PSEC

Dividends

PRCT vs. PSEC - Dividend Comparison

PRCT has not paid dividends to shareholders, while PSEC's dividend yield for the trailing twelve months is around 16.82%.


TTM20232022202120202019201820172016201520142013
PRCT
PROCEPT BioRobotics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PSEC
Prospect Capital Corporation
16.82%12.02%10.30%9.27%13.31%11.18%11.41%13.41%11.93%14.67%16.04%11.76%

Drawdowns

PRCT vs. PSEC - Drawdown Comparison

The maximum PRCT drawdown since its inception was -63.51%, roughly equal to the maximum PSEC drawdown of -61.51%. Use the drawdown chart below to compare losses from any high point for PRCT and PSEC. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-6.88%
-33.97%
PRCT
PSEC

Volatility

PRCT vs. PSEC - Volatility Comparison

PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 31.20% compared to Prospect Capital Corporation (PSEC) at 16.37%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than PSEC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%JuneJulyAugustSeptemberOctoberNovember
31.20%
16.37%
PRCT
PSEC

Financials

PRCT vs. PSEC - Financials Comparison

This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and Prospect Capital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items